Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Understand how income and capital gains from dividend ETFs differ and why tax efficiency matters. This intro explains the basic tradeoffs and what factors influence your after-tax results.
27,312 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Alphabet is stepping up its AI game, signaling big potential and bigger risks for investors. This piece breaks down w...
Netflix is evolving from a streaming naysayer to a diversified media platform. This guide weighs the case for netflix...
Investors are buzzing about SpaceX's ambitious revenue target for 2030 and a bold rival coming from AI. This guide br...
A new program from Morgan Stanley allows eligible wealth clients to lend crypto to Galaxy Digital in exchange for spo...
Meta’s Hyperion project is turning a quiet Louisiana parish into a sprawling AI hub, with thousands of workers, local...
U.S. stocks pulled back after signals that a ceasefire may be unraveling, lifting oil and turning traders toward safe...
A growth stock down 2026 may look like a setback, but it can become a powerful opportunity for patient investors. Thi...
Awards shine briefly, but investors chase cash flow, growth, and disciplined capital allocation. This guide shows how...
Rent prices are down nationwide, but smart investors aren’t scrambling — they’re adapting. This guide shares concrete...
BitMine expands its Ethereum hoard to 60,000 ETH worth about $126 million as it enters the Russell 1000 preliminary l...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...